Press Release: M3 Global Research Acquires Med Planet
Global Healthcare Market Research Leader Strengthens Capabilities and Reach in France with Latest Acquisition
FORT WASHINGTON, PA (April 12, 2023) — M3 Global Research announced today the acquisition of Med Planet. With over 25 years of experience providing comprehensive qualitative research services to the life sciences industry, Med Planet’s local expertise is unparalleled, and further strengthens M3’s commitment to excellence in major European markets. This announcement follows the acquisition of Germany’s pharma-insight in May 2022, and further consolidates M3’s ambitions for aggressive global growth.
Founded in 1997 by Maillou Enselme, who will continue at the helm, and headquartered in Lyon, France, Med Planet’s success reflects their ambitions to deliver comprehensive qualitative research solutions to a growing client roster, coupled with real passion for excellence in results.
“We’re proud to announce further expansion of our European operations,” said M3 Global Research’s CEO Anton Richter. “Med Planet’s reputation for excellence in their field precedes them, and France is an important market for M3 and our clients, who will find Med Planet’s on-the-ground local expertise invaluable.”
Med Planet founder, Maillou Enselme on the acquisition: “We’re delighted to join M3 and look forward to the future growth of our organisation thanks to the extensive investment in resources and technology that M3 will deliver. Our future is incredibly bright, and we are very excited about the opportunities the acquisition provides for us and our extremely valued client roster.”
The acquisition further strengthens M3’s European presence, which now includes physical locations in France, the United Kingdom, Germany, and Sweden.
The M3 Group operates in the US, Asia, and Europe with over 6 million physician members globally via its physician websites which include m3globalresearch.com, mdlinx.com, m3.com, research.m3.com, doctors.net.uk, medigate.net, medlive.cn, and m3india.in. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, Australia, France, Japan, China, and India. The M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Japan, UK, France, Germany, Spain, USA, Sweden, China, South Korea, and India.
Med Planet has over 25 years of experience providing qualitative market research services to the healthcare industry. Headquartered in Lyon, France, Med Planet specialise in a consultative approach, entrenched in local expertise, to ensure their clients benefit from high quality outputs and actionable data.
Tel: +44 (0)7989 689594
Email: hbrown@m3global.com
